Lucence Diagnostics Pte LTD
Lucence is a precision oncology company bringing clarity to cancer care. Lucence makes ultrasensitive liquid biopsy tests to provide doctors and their patients life-changing information to enable earlier detection and effective treatment. Lucence’s LiquidHALLMARK cfDNA and cfRNA panel combines cfRNA profiling of 27 fusions with cfDNA profiling of mutations in 80 genes, fusions in 10 genes, and somatic variants in 15 cancer types. Headquartered in Palo Alto, Lucence provides personalized diagnostics through twin CAP-accredited, CLIA-licensed laboratories in California and Singapore.
Additional Info
Will your company display a new product or promote a new indication/enhanced feature(s) for an existing product in your booth?
Yes